Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Basavarajappa, Halesha D. | - |
dc.contributor.author | Lee, Bit | - |
dc.contributor.author | Lee, Hyungjun | - |
dc.contributor.author | Sulaiman, Rania S. | - |
dc.contributor.author | An, Hongchan | - |
dc.contributor.author | Magana, Carlos | - |
dc.contributor.author | Shadmand, Mehdi | - |
dc.contributor.author | Vayl, Alexandra | - |
dc.contributor.author | Rajashekhar, Gangaraju | - |
dc.contributor.author | Kim, Eun-Yeong | - |
dc.contributor.author | Suh, Young-Ger | - |
dc.contributor.author | Lee, Kiho | - |
dc.contributor.author | Seo, Seung-Yong | - |
dc.contributor.author | Corson, Timothy W. | - |
dc.date.accessioned | 2021-09-04T15:00:35Z | - |
dc.date.available | 2021-09-04T15:00:35Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2015-06-25 | - |
dc.identifier.issn | 0022-2623 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/93237 | - |
dc.description.abstract | Eye diseases characterized by excessive angiogenesis such as wet age-related macular degeneration, proliferative diabetic retinopathy, and retinopathy of prematurity are major causes of blindness. Cremastranone is an antiangiogenic, naturally occurring homoisoflavanone with efficacy in retinal and choroidal neovascularization models and antiproliferative selectivity for endothelial cells over other cell types. We undertook a cell-based structure activity relationship study to develop more potent cremastranone analogues, with improved antiproliferative selectivity for retinal endothelial cells. Phenylalanyl-incorporated homoisoflavonoids showed improved activity and remarkable selectivity for retinal microvascular endothelial cells. A lead compound inhibited angiogenesis in vitro without inducing apoptosis and had efficacy in the oxygen-induced retinopathy model in vivo. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.subject | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject | MACULAR DEGENERATION | - |
dc.subject | CELL-PROLIFERATION | - |
dc.subject | IN-VITRO | - |
dc.subject | ANGIOGENESIS | - |
dc.subject | INHIBITION | - |
dc.subject | THERAPY | - |
dc.subject | HYACINTHACEAE | - |
dc.subject | RANIBIZUMAB | - |
dc.subject | BEVACIZUMAB | - |
dc.title | Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kiho | - |
dc.identifier.doi | 10.1021/acs.jmedchem.5b00449 | - |
dc.identifier.scopusid | 2-s2.0-84933054586 | - |
dc.identifier.wosid | 000357139000014 | - |
dc.identifier.bibliographicCitation | JOURNAL OF MEDICINAL CHEMISTRY, v.58, no.12, pp.5015 - 5027 | - |
dc.relation.isPartOf | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.title | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.volume | 58 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 5015 | - |
dc.citation.endPage | 5027 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.subject.keywordPlus | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject.keywordPlus | MACULAR DEGENERATION | - |
dc.subject.keywordPlus | CELL-PROLIFERATION | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | ANGIOGENESIS | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | HYACINTHACEAE | - |
dc.subject.keywordPlus | RANIBIZUMAB | - |
dc.subject.keywordPlus | BEVACIZUMAB | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.